ENEXIS
Overview
ENEXIS is a Swedish investment company focused on the European legal cannabis and plant-based industries, mainly in the wellness and healthcare sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DEMECAN | Dec 2022 | VC Round | Co-investor |
| Alphagreen Group | Nov 2020 | Seed | Co-investor |
| Octarine Bio | Nov 2020 | Seed | Co-investor |
| Valcon Medical A/S | May 2022 | Series C | Lead |
| Eden Partners LLC | Oct 2018 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ENEXIS based?
ENEXIS is headquartered in Stockholm, Sweden.
When was ENEXIS founded?
ENEXIS was founded in 2018.
How many portfolio companies does ENEXIS have?
ENEXIS has 6 portfolio companies in Caplight's dataset.
What are some companies in ENEXIS's portfolio?
Portfolio companies visible on Caplight include DEMECAN, Alphagreen Group, Octarine Bio, Valcon Medical A/S, Eden Partners LLC.
What was ENEXIS's most recent investment shown here?
ENEXIS's most recent investment in this portfolio sample was in DEMECAN in 2022.
What sectors does ENEXIS focus on?
ENEXIS focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Energy & Sustainability, Consumer & Commerce, Enterprise Software, Media, Entertainment & Gaming, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does ENEXIS focus on?
ENEXIS typically invests at the Early stage.